ScreenerHero

EOCN Eocene Ltd.

NAS · US · Healthcare · Biotechnology · eocn.com
3.080USD-2.22%Mkt Cap: 3.29M $P/E: —

Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile a…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$131.98BUSDP/E 30.3
REGN
Regeneron Pharmaceuticals, Inc.
$84.02BUSDP/E 20.2
MRNA
Moderna, Inc.
$83.03BUSD
CSL
CSL Limited
$66.33BUSD
UCB
UCB SA
$57.32BUSDP/E 23.7
ARGX
argenx SE
$55.50BUSDP/E 30.6
ARGX
argenx SE
$55.08BUSDP/E 31.5
ONC
BeOne Medicines AG
$41.65BUSDP/E 65.5
RVMD
Revolution Medicines, Inc.
$39.91BUSD
RPRX
Royalty Pharma plc
$37.72BUSDP/E 34.7
ALNY
Alnylam Pharmaceuticals, Inc.
$30.35BUSDP/E 38.2
GMAB
Genmab A/S
$27.58BUSDP/E 37.0
GMAB
Genmab A/S
$27.47BUSDP/E 35.2
ROIV
Roivant Sciences Ltd.
$26.39BUSD
INCY
Incyte Corporation
$23.63BUSDP/E 14.9
BNTX
BioNTech SE
$21.87BUSD
INSM
Insmed Incorporated
$20.74BUSD
EXEL
Exelixis, Inc.
$16.19BUSDP/E 20.6
ASND
Ascendis Pharma A/S
$16.18BUSDP/E 18.8
HALO
Halozyme Therapeutics, Inc.
$14.58BUSDP/E 37.6

Key Statistics

Company
Market Cap3.29M USD
Enterprise Value-7.95M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.31M USD
Revenue/Share—
Last Price3.080 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.24
EPS (TTM)-15.21
EPS (Forward)—
52W Range
2.3308% of range12.32
52W High12.32 USD
52W Low2.330 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-65.32%
ROA-55.34%
ROIC—
ROCE-53.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.32M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-160.32%
Net Debt-11.10M USD
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity1.01
Current Ratio4.16
Quick Ratio4.11
Book Value/Sh12.72 USD
Cash/Share11.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateAug 19, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.07M
Float977.02K
Insiders3.04%
Institutions1.89%
Short Interest
Short Ratio0.4d
Short % Float1.35%
Short % Out.1.32%
Shares Short14.11K
Short (prev mo.)4.66K
Technical
SMA 503.702 (-16.8%)
SMA 2004.676 (-34.1%)
Beta0.66
S&P 52W Chg10.89%
Avg Vol (30d)7.24K
Avg Vol (10d)7.87K
Technical Indicators
RSI (14)41.6
MACD-0.1872
MACD Signal-0.2094
MACD Hist.+0.0222
BB Upper3.714 USD
BB Middle3.230 USD
BB Lower2.746 USD
BB Width29.97%
ATR (14)0.2692 USD
Vol Ratio (20d)0.27x